🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the safety and effectiveness of giving rivogenlecleucel...
Status
Terminated
Location
TriStar Bone Marrow Transplant, LLC
Start Date
2018-12-27
Trial ID
NCT03699475
Treatments Being Tested
This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-10-01
Trial ID
NCT05900401
This is a Phase II pilot study of chemotherapy and surgery for children wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-10
Trial ID
NCT00186849
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of vaccine the...
Status
Completed
Location
Mayo Clinic
Start Date
2006-11-30
Trial ID
NCT00450814
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested